Evidence map›Paper›PMID 25914354›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Tandem Z-Selective Cross-Metathesis/Dihydroxylation: Synthesis of anti-1,2-Diols.

Peter K Dornan, Zachary K Wickens, Robert H Grubbs

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Cationic ruthenium alkylidene catalysts bearing phosphine ligands.Dalton transactions (Cambridge, England : 2003) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter K DornanDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125 (USA).
Zachary K WickensDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125 (USA).
Robert H GrubbsDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125 (USA). rhg@caltech.edu.

Funding

REAGENTS FOR ORGANIC SYNTHESIS BASED ON TRANSITION METALR01GM031332 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRUBBS, ROBERT HOWARD · 1985 to 2016
$6.1M
400 MHz Nuclear Magnetic Resonance SpectrometerS10RR027690 · NCRR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VANDERVELDE, DAVID G · 2010 to 2010
$315k
NCRR NIH HHS RR027690NCRR NIH HHS S10 RR027690NIGMS NIH HHS R01 GM031332PHS HHS 5R01M031332-27
6 · The paper itself

Abstract

A stereoselective synthesis of anti-1,2-diols has been developed using a multitasking Ru catalyst in an assisted tandem catalysis protocol. A cyclometalated Ru complex catalyzes first a Z-selective cross-metathesis of two terminal olefins, followed by a stereospecific dihydroxylation. Both steps are catalyzed by Ru, as the Ru complex is converted to a dihydroxylation catalyst upon addition of NaIO4. A variety of olefins were transformed into valuable, highly functionalized, and stereodefined molecules. Mechanistic experiments were performed to probe the nature of the oxidation step and catalyst inhibition pathways. These experiments point the way to more broadly applicable tandem catalytic transformations.

Indexed as

AlcoholsAlkenesCatalysisCoordination ComplexesCrystallography, X-RayHydroxylationMolecular ConformationRutheniumStereoisomerismAlcoholsAlkenesCoordination ComplexesRutheniumanti-diolsdihydroxylationmetathesistandem reactionsZ-selectivity

Identifiers

PMID25914354
PMCPMC4547607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.